Equities
Health CareHealth Care Equipment & Services
  • Price (GBX)1,322.00
  • Today's Change-11.00 / -0.83%
  • Shares traded3.32m
  • 1 Year change5.93%
  • Beta0.8413
Data delayed at least 20 minutes, as of Sep 20 2017 17:02 BST.
More ▼

Key statistics

On Wednesday, Smith & Nephew PLC (SN.:LSE) closed at 1,322.00, -6.37% below its 52-week high of 1,412.00, set on Sep 11, 2017.
52-week range
Today
1,064.91Nov 14 20161,412.00Sep 11 2017
Markit short selling activity
Low
Med
High
Open1,329.00
High1,336.00
Low1,320.00
Bid1,320.00
Offer1,325.00
Previous close1,333.00
Average volume4.50m
Shares outstanding874.84m
Free float867.11m
P/E (TTM)18.38
Market cap11.65bn GBP
EPS (TTM)0.7246
GBP
Annual div (ADY)23.92
GBX
Annual div yield (ADY)1.79%
Div ex-dateMar 30 2017
Div pay-dateMay 10 2017
Next div ex-dateOct 05 2017
Next div pay-dateNov 01 2017
Data delayed at least 20 minutes, as of Sep 20 2017 17:02 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Smith & Nephew PLC shares was Hold at 1,332.00 on 28 Jul 2017Read the full article
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.